cytidine diphosphate has been researched along with Fatty Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakovic, M; Bonen, A; Fullerton, MD; Hakimuddin, F | 1 |
| Frank, MW; Jackowski, S; Jackson, PD; Leonardi, R; Rock, CO | 1 |
2 other study(ies) available for cytidine diphosphate and Fatty Liver
| Article | Year |
|---|---|
The development of a metabolic disease phenotype in CTP:phosphoethanolamine cytidylyltransferase-deficient mice.
Topics: Animals; Cytidine Diphosphate; Diglycerides; Ethanolamines; Fatty Liver; Female; Gene Expression Regulation; Hypertriglyceridemia; Insulin Resistance; Lipid Metabolism, Inborn Errors; Male; Metabolic Syndrome; Mice; Mice, Knockout; Phosphatidylethanolamines; Phosphatidylserines; RNA Nucleotidyltransferases; Triglycerides | 2009 |
Elimination of the CDP-ethanolamine pathway disrupts hepatic lipid homeostasis.
Topics: Animals; Cytidine Diphosphate; Ethanolamine; Fatty Liver; Female; Gene Expression Regulation; Gene Knockout Techniques; Homeostasis; Lipid Metabolism; Lipogenesis; Liver; Male; Mice; Organ Specificity; Phosphatidylethanolamines; RNA Nucleotidyltransferases; RNA, Messenger; Transcription, Genetic; Triglycerides | 2009 |